Allecra Therapeutics
Trending Articles
Related Content
Regulatory
Allecra announces fast track designation for antibiotic
Allecra Therapeutics, a biopharmaceutical company dedicated to the development of novel antibiotics for the treatment of drug-resistant bacterial infections, announced the US FDA has granted fast track designation for the company’s lead product candidate AAI101 when given in fixed dose combination with the antibiotic cefepime